There are currently 183 active clinical trials seeking participants for Heart Failure research studies. The states with the highest number of trials for Autism participants are California, Florida, Texas and Pennsylvania.
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
NCT06130059
Recruiting
The purpose of this research study is to determine the effectiveness of low dose colchicine (LoDoCo) on measures of exercise capacity, physical function, frailty, and quality of life, among patients with heart failure with chronic stable preserved ejection fraction (HFpEF) and systemic inflammation. The use of LoDoCo in this study is considered investigational as it has not been approved by the Food and Drug Administration (FDA) for the treatment of exercise capacity in patients with HFpEF. Par... Read More
Gender:
All
Ages:
50 years and above
Trial Updated:
04/26/2024
Locations: UT Southwestern Medical Center, Dallas, Texas
Conditions: Heart Failure, Inflammation
Register for Updates
A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure
NCT06142383
Recruiting
This is a multicenter, randomized, placebo- and active-controlled, parallel-group, 24-week trial to investigate the efficacy, safety, and tolerability of XXB750 in participants with HFrEF/HFmrEF.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/25/2024
Locations: SEC Clinical Research Research, Dothan, Alabama +65 locations
Conditions: Heart Failure
Register for Updates
XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)
NCT05881278
Recruiting
The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/23/2024
Locations: University of California San Diego, La Jolla, California +8 locations
Conditions: Heart Failure, Transplant; Failure, Heart
Register for Updates
Pharmacokinetics and Pharmacodynamics of Subcutaneous vs Intravenous Furosemide in Healthy Volunteers
NCT06167707
Recruiting
This study aims to compare the pharmacokinetics and pharmacodynamics of intravenous (IV) and subcutaneous (SC) furosemide. The test formulation in this study is furosemide injection, 80 mg/1 mL, buffered to a neutral pH for SC administration via an autoinjector. A commercial formulation of furosemide injection, USP, solution 10 mg/mL administered as a 40 mg IV injection over 2 minutes followed by a second dose of 40 mg, 2 hours later, will serve as the reference drug. The objectives of this stu... Read More
Gender:
All
Ages:
Between 45 years and 80 years
Trial Updated:
04/19/2024
Locations: Elixia EPCT, LLC, Tampa, Florida
Conditions: Heart Failure, Fluid Overload
Register for Updates
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
NCT06378632
Recruiting
Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively analyzed to determine the sensitivity and UPNR of the HearO system.
Gender:
All
Ages:
22 years and above
Trial Updated:
04/18/2024
Locations: Eastern Shore Research Institute, Fairhope, Alabama +43 locations
Conditions: Heart Failure
Register for Updates
BATwire Implant Kit
NCT04600791
Recruiting
The purpose of this clinical investigation is to develop valid scientific evidence for the safety and effectiveness of the Barostim System delivered by the BATwire Implant Kit (BATwire Kit) in subjects with heart failure. Subjects may be enrolled if they meet the FDA approved PMA indication for use for the Barostim NEO or Barostim NEO2 device: Subjects who remain symptomatic despite treatment with guideline-directed medical therapy, are NYHA Class III or Class II (who had a recent history of Cla... Read More
Gender:
All
Ages:
Between 21 years and 80 years
Trial Updated:
04/18/2024
Locations: Chan Heart Rhythm Institute, Mesa, Arizona +13 locations
Conditions: Heart Failure
Register for Updates
NAN-101 in Patients With Class III Heart Failure
NCT04179643
Recruiting
This is a Phase 1, prospective, multi-center, open-label, sequential dose escalation study to explore the safety, feasibility, and efficacy of a single intracoronary infusion of BNP116.sc-CMV.I1c in patients with NYHA Class III heart failure. Patients with symptomatic congestive heart failure will be enrolled until up to 12 subjects have received infusions of investigational product. All patients will be followed until 12 months post treatment intervention, and then undergo long-term follow-up v... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/18/2024
Locations: Minneapolis Heart Foundation Institute, Minneapolis, Minnesota +3 locations
Conditions: Congestive Heart Failure, Heart Failure, Heart Disease, Ischemic, Cardiovascular Diseases, Heart Failure, Systolic, Heart Failure，Congestive, Heart Arrhythmia, Heart Failure, Diastolic, Heart; Complications
Register for Updates
Implantable Cardioverter Defibrillator (ICD Registry)
NCT01999140
Recruiting
The ICD Registry™ is a nationwide quality program that helps participating hospitals measure and improve care for patients receiving implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices with defibrillator (CRT-Ds). The ICD Registry captures the characteristics, treatments, and outcomes of patients receiving (ICDs). Patient-level data is submitted by participating hospitals on a quarterly basis to the American College of Cardiology Foundation's (ACCF) Natio... Read More
Gender:
All
Ages:
All
Trial Updated:
04/17/2024
Locations: American College of Cardiology/National Cardiovascular Data Registry (NCDR), Washington, District of Columbia
Conditions: Heart Failure, Nonischemic Cardiomyopathy, Ischemic Cardiomyopathy, Ventricular Arrhythmia, Complications; Device, Cardiac
Register for Updates
Food Supplementation Delivered Conditionally vs Not Among Patients With Heart Failure
NCT06115369
Recruiting
The current study proposes to investigate if the provision of healthy food can improve outcomes following discharge after HF hospitalization. To investigate this in an efficient and pragmatic manner, a 2x2 factorial randomized control trial design will be utilized to simultaneously investigate two separate, important food-related questions: Does the provision of 90 days of either medically-tailored meals or fresh produce boxes improve 90-day patient outcomes among those with HF relative to a co... Read More
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
04/16/2024
Locations: UT Southwestern Medical Center, Dallas, Texas
Conditions: Heart Failure
Register for Updates
Assessment of CCM in HF With Higher Ejection Fraction
NCT05064709
Recruiting
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤60%.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/16/2024
Locations: Grandview Medical Group Research, LLC, Birmingham, Alabama +100 locations
Conditions: Heart Failure, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction, Heart Failure With Moderately Reduced Ejection Fraction, Diastolic Heart Failure
Register for Updates
A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT05592275
Recruiting
The main purpose of this study is to assess the efficacy and safety of LY3540378 in adults with worsening heart failure with preserved ejection fraction
Gender:
All
Ages:
18 years and above
Trial Updated:
04/16/2024
Locations: Valley Clinical Trials, Inc., Covina, California +129 locations
Conditions: Heart Failure, Heart Failure With Preserved Ejection Fraction
Register for Updates
Virtual Reality and Computerized Cognitive Intervention for Mild Cognitive Impairment in Heart Failure
NCT05601817
Recruiting
This research project is relevant to public health because both heart failure (HF) and mild cognitive impairment (e.g., trouble remembering and concentrating beyond normal aging) are highly prevalent among older adults in the United States. Despite advances in health care, there are no effective interventions for treating cognitive impairment in HF, which if left untreated, leads to suboptimal health, quality of life, and shorter survival. Therefore, the investigators propose to test the effect... Read More
Gender:
All
Ages:
55 years and above
Trial Updated:
04/16/2024
Locations: Indiana University, Indianapolis, Indiana
Conditions: Heart Failure, Mild Cognitive Impairment
Register for Updates